Enel Health®Atlas
Sign in
Enel Health®Atlas
Browse libraries

Not medical advice. The Atlas is not a substitute for a clinician who can examine you.

Hematospermia

Blood in the semen, causes, workup, and red flags

Evidence grade 3 of 5, Mixed. Read how the Atlas grades evidence.

The written rationale for this grade is still being prepared.

FDA
Not applicable, a symptom evaluated with established urologic workup

Reference only. Not medical advice.

What can go wrong

The main risk is missing a treatable infection or, uncommonly, a prostate or other genitourinary malignancy in older men. A digital rectal exam, urinalysis, blood pressure check, and, per age and risk, PSA are reasonable first steps. Coagulation studies are sometimes recommended for persistent cases. Reassurance is appropriate for low-risk single episodes, but persistence or red flags should prompt urologic referral.

This is something to take to a clinician. The Atlas can tell you what is known about hematospermia in general. It cannot tell you what is happening in your body, and the difference matters most for exactly the symptoms that bring people to this page.

Hematospermia is the presence of visible blood in the ejaculate. In most men, especially those under 40 with a single or short-lived episode, it is benign and self-limited, most often linked to inflammation or infection of the seminal vesicles or prostate. The workup escalates with age, persistence (commonly cited thresholds of 1-3 months), and risk factors: in older men or those with red flags, evaluation may include PSA, urinalysis, STI testing, transrectal ultrasound, MRI, and sometimes cystoscopy to exclude infection, stones, cysts, obstruction, vascular causes, and, rarely, malignancy.

Usually benign and self-limited, but age and persistence change the calculus.

What people take it for

These are the reasons people give for taking it. They are not effects it has been shown to have.

  • Framework for reassurance versus investigation of blood in semen

How it is supposed to work

Bleeding can originate anywhere along the ejaculatory tract, prostate, seminal vesicles, ejaculatory ducts, vas, epididymis, or urethra. Etiologic categories include inflammatory/infectious, lithiasis (stones), cystic, obstructive, tumoral, vascular, traumatic, iatrogenic (e.g., after prostate biopsy), and systemic (such as coagulopathy or uncontrolled hypertension).

Safety in detail

Persistent hematospermia, or any episode in a man over 40 or with urinary symptoms, fever, or risk factors, should be evaluated by a urologist. Imaging and prostate-related testing require physician oversight.

What people get wrong

  • Often saidBlood in semen means cancer

    ActuallyIn most men, particularly under 40, it is benign and infection- or inflammation-related. Malignancy is an uncommon cause, more relevant in older men or with persistent symptoms.

  • Often saidEvery case needs an MRI and biopsy

    ActuallyA young man with one painless episode and a normal exam typically needs only basic testing. Imaging and invasive workup are reserved for persistent cases, older age, or red flags.

Who profits, and who pushes back

Nobody is named here yet, because we have not done that work on this entry. Read that as unfinished. Somebody almost certainly sells this, and somebody almost certainly disputes it. Assume both until we have checked.

At a glance

Most common cause
Inflammation/infection of prostate or seminal vesicles
Lower-concern profile
Under 40, single episode, no other symptoms
Escalate workup
Persistent (>~1-3 months), age >40, or risk factors
Key imaging
Transrectal ultrasound; MRI best shows hemorrhage in seminal vesicles

What this entry does not yet cover

What follows is unfinished work on our side, not a finding about Hematospermia. A short entry is not a safe entry.

  • Timeline. We have not built the dated record of research and regulatory events.
  • Cost and market. We have not documented what it sells for or who sells it.
  • Supply chain. We have not mapped where it is made.
  • Who uses it. We have not documented the user groups.
  • What could change. No forward-looking summary yet.
  • How it compares. We have not set it against the alternatives.
  • Children and teenagers. We have not checked what is known about younger people.
  • Where we land. We have not taken a position on this yet.

Sources

The studies below are named and described, but not linked. You cannot open them from here and check our reading against them, which means this page is our summary of the literature rather than a document you can verify. Weigh it accordingly until the links exist.

The studies that matter

  • Prando, endorectal MRI in chronic hematospermia2008

    Found endorectal MRI highly sensitive for abnormalities underlying chronic hematospermia, most of which were benign

  • Systematic reviews of hematospermia workup2014-2017

    Support age- and persistence-stratified evaluation rather than aggressive imaging in young men with isolated episodes